New Delhi: Aurobindo Pharma on Saturday said its consolidated net profit increased 61 per cent year on year to Rs 919 crore in the first quarter ended June 2024, aided by strong sales across markets. The Hyderabad-based drug maker had reported a net profit of Rs 571 crore in the April-June quarter of last fiscal. … Read more
Benchmark Sensex and Nifty closed at new record high levels on Monday following buying in PSU bank shares and fresh foreign fund inflows. Stocks that were in focus include names like Aurobindo Pharma, which soared 3.67%, Tanla Platforms, which gained 5.69%, and IDBI Bank, whose shares Jumped 6.79% on Monday. Here’s what Kushal Gandhi, Technical … Read more
Indian Railway Finance Corporation Share Price 216.32 03:59 PM | 15 Jul 2024 -1.12(-0.52%) One97 Communications Share Price 469.65 03:59 PM | 15 Jul 2024 3.7(0.8%) YES Bank Share Price 26.38 04:00 PM | 15 Jul 2024 0.78(3.05%) ITC Share Price 463.4 03:59 PM | 15 Jul 2024 4.35(0.95%) HDFC Bank Share Price 1622.1 03:59 … Read more
Domestic markets experienced one of the best weeks in 2024 with Nifty and Sensex extending closing at record highs last week. In today’s trade, shares of HCL Tech, DMart, Jio Financial, HDFC Life, Kotak Bank among others will be in focus due to news developments and first quarter results. HDFC Life, Jio Financial, HDFC AMC, … Read more
DHARMESH SHAH, HEAD OF TECHNICALS, ICICI SECURITIESWhere is Nifty headed this week?We expect Nifty to continue trade with a positive bias and gradually head towards 24,700 by July end. Higher peaks and troughs supported by market breadth signifies inherent strength (currently 86% of stocks are trading above 50-day EMAs), and the global setup continues to … Read more
“Nykaa is a stock which I always believed will perform at some stage. Now, we are coming at a stage where the company is trying to get some costs under control and we could potentially have some benefits coming to individual taxpayers to boost personal consumption, then Nykaa could actually be a performer,” says Sandip … Read more
Brokerage Macquarie maintained an outperform rating on Aurobindo Pharma, Morgan Stanley initiated coverage on Suzlon, CLSA upgraded Apollo Hospital and CLSA maintained a buy rating on Titan Company. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Aurobindo Pharma: Outperform | Target Rs 1,385Macquarie maintained an … Read more
The price movement for Aurobindo Pharma has been in a broad range since November 2023 wherein the stock has taken support near Rs 985 levels a few times while on the upside, it shows a resistance near its all-time high level of Rs 1,177. Post 19th March, the stock has been in a broader uptrend … Read more
May 03, 2024, 10:41:46 AM IST FY24 proved to be an exceptional year for equity markets worldwide, with Indian equity markets exhibiting outstanding performance. Throughout the year, Indian equities consistently achieved new all-time highs, accompanied by continuous surges in market volumes. In April 2024, mid and smallcap indices rallied by 6% and 11% respectively while … Read more
Global brokerage Morgan Stanley maintained an overweight rating on Dalmia Bharat, Macquarie recommended an outperform rating on Axis Bank, Jefferies maintained a hold rating on Kotak Mahindra Bank and Investec has a buy rating on Aurobindo Pharma. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Morgan Stanley … Read more
